Cargando…
TPO/Mpl Studies in Agnogenic Myeloid Metaplasia
BACKGROUND: Agnogenic myeloid metaplasia (AMM) is one of the Philadelphia chromosome negative myeloproliferative disorder and is diagnosed by hyperplasia of atypical megakaryocytes, hepatosplenomegaly, extramedullary hematopoiesis and bone marrow fibrosis. Fibrosis is considered to be a secondary co...
Autores principales: | Hemavathy, Kirugaval C, Suppiah, Kathir, Hashmi, Gazala, Novetsky, Allan D, Wang, Jen C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549047/ https://www.ncbi.nlm.nih.gov/pubmed/15691382 http://dx.doi.org/10.1186/1478-811X-3-4 |
Ejemplares similares
-
Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated Megakaryocytopoiesis
por: Tong, Wei, et al.
Publicado: (2004) -
c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis
por: Li, Liang, et al.
Publicado: (2020) -
Agnogenic practices: an analysis of UK gambling industry-funded youth education programmes
por: van Schalkwyk, MCI, et al.
Publicado: (2022) -
Agnogenic massive pulmonary embolism with syncope as initial symptom: A case report and review of the literature
por: JIANG, AI-GUI, et al.
Publicado: (2013) -
Agnogene Deletion in a Novel Pathogenic JC Virus Isolate Impairs VP1 Expression and Virion Production
por: Ellis, Laura C., et al.
Publicado: (2013)